IQVIA (NYSE:IQV – Free Report) had its price target hoisted by Citigroup from $190.00 to $225.00 in a report released on Monday, Benzinga reports. The firm currently has a neutral rating on the medical research company’s stock. A number of other analysts also recently issued reports on the stock. Evercore ISI cut their price target […]